The role of bacterial muramyl dipeptide as a postbiotic has also been documented in reducing inflammation and promoting insulin signaling in the state of metabolic endotoxemia, glycemia, and obesity via a pathway that involves NOD2 (30). This evidence concerns the gene INS and Obesity.